logo
Select company
Select metric
$ -209KNet Cash Flow - Issuance (Purchase) of Equity Shares
VS
Market
58
Sector
84
Industry
95
History
100
$ 0.54Close
$ 0.39 - $ 1.72 52-Week Range
Ticker Information

Ticker

IPSC

Company Name

CENTURY THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CENTURY THERAPEUTICS INC - Net Cash Flow - Issuance (Purchase) of Equity Shares Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

IPSC - CF - Equity Historical data
DateNet Cash Flow - Issuance (Purchase) of Equity Shares
6/30/2025$ -209K
3/31/2025$ 56.49M
12/31/2024$ 74.56M
9/30/2024$ 74.81M
6/30/2024$ 74.84M
3/31/2024$ 18.26M
12/31/2023$ 516K
9/30/2023$ 967K
6/30/2023$ 805K
3/31/2023$ 728K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CENTURY THERAPEUTICS INC's latest trailing twelve months (TTM) CF - Equity stands at $ 38.1M.
  • Over the past 5 years, CENTURY THERAPEUTICS INC's average CF - Equity has been $ 58.09M.
  • The median CF - Equity for CENTURY THERAPEUTICS INC during this period was $ 27.16M
  • CENTURY THERAPEUTICS INC reached its highest CF - Equity over the past 5 years at $ 258.15M.
  • The lowest CF - Equity recorded by CENTURY THERAPEUTICS INC in the same timeframe $ -209K

CENTURY THERAPEUTICS INC's CF - Equity vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Equity Benchmarks
CompanyCF - Equity
STRO : SUTRO BIOPHARMA INC $ 1.34MKPTI : KARYOPHARM THERAPEUTICS INC $ 680KFBIO : FORTRESS BIOTECH INC $ 9.29MIGMS : IGM BIOSCIENCES INC $ 1.64MVERU : VERU INC $ 0MRSN : MERSANA THERAPEUTICS INC $ 257KADAP : ADAPTIMMUNE THERAPEUTICS PLC $ 1.79MXCUR : EXICURE INC $ 14MATNM : ACTINIUM PHARMACEUTICALS INC $ 4.6MALGS : ALIGOS THERAPEUTICS INC $ 101.71M

Definition of Net Cash Flow - Issuance (Purchase) of Equity Shares

[Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from stock issuance (purchase).

IPSC - Net Cash Flow - Issuance (Purchase) of Equity Shares, Last 5 years

$ -209K

Minimum

Jun 30, 2025

$ 258.15M

Maximum

Dec 31, 2021

$ 58.09M

Average

$ 27.16M

Median

CF - Equity Benchmark Analysis

The chart above depicts the distribution of CF - Equity for companies in the Total Stock Market. The average CF - Equity of the companies is $ 124.49K with a standard deviation of $ 17.66M.
The following table provides additional summary stats:
CF - Equity in the Market:
filtered constituents2.9K
min$ -60.59M
max$ 60.64M
average$ 124.49K
median$ 0
std$ 17.66M